Announcements

The latest company announcements from Denmark, Sweden, Norway and Finland

Duell Favicon

Duell has executed a reverse split

Duell Corporation (“Duell” or “Company”) has today, November 22, 2024, on the previously announced combination date executed a reverse split, i.e., the reduction of the number of shares in the Company, and a related directed share issue without consideration, redemption of shares and cancellation of shares. After these measures, the new number of shares in the Company is 5,194,374. The new number of shares has been registered with the Trade Register maintained by the Finnish Patent and Registration Office today, November 22, 2024, and trading with the new total number of shares in the Company commences on Monday November 25, 2024 with a new ISIN code FI4000582143. Duell’s trading code DUELL will remain the same.

Duell’s Annual General Meeting resolved on November 20, 2024 on the reverse split and on a related redemption of shares so that after carrying out the reverse split, every 200 shares in the Company corresponds to one (1) share in the Company. Concurrently with the execution of the reverse split, the Board of Directors of the Company has today resolved on implementing the directed share issue without consideration resolved by the Annual General Meeting in which the Company has issued without consideration a total of 328,684 new shares in such manner that the number of shares in each book-entry account holding Duell’s shares has been made divisible by 200. The aggregate market value of the shares issued without consideration is EUR 12,818.68, based on the closing price of November 22, 2024.

After the directed share issue, the Company has redeemed without consideration 199 shares for each 200 shares in the Company, in accordance with the resolution of the Annual General Meeting. The Company’s shares redeemed in connection with the reverse split have been cancelled immediately. After the reverse split, Duell holds 33,800 treasury shares.

The purpose of the reverse split is to increase the value of a single share to facilitate trading conditions of the company’s shares and improve price formation of the company’s shares. The procedure has been explained in more detail in Duell’s company release on the resolutions of the Company’s Annual General Meeting, issued on November 20, 2024.

Duell Corporation

Further information:

Pellervo Hämäläinen, Communications and IR ManagerDuell Corporation+358 40 674 5257pellervo.hamalainen@duell.eu

Certified Adviser

Oaklins Finland Ltd+358 9 312 9670 

Duell Corporation (Duell) is an import and wholesale company based in Mustasaari, Finland, established in 1983. Duell imports, manufactures, and sells products through an extensive distribution network in Europe covering approximately 8,500 dealers. The range of products includes around 150,000 items under more than 500 brands. The assortment covers spare parts and accessories for Motorcycling, Bicycling, ATVs/UTVs, Snowmobiling, Marine and Garden/Forest categories. Logistics centres are in Finland, Sweden, Netherlands, France, and the UK. Duell’s net sales in financial year 2024 was EUR 125 million and it employs over 200 people. Duell’s shares (DUELL) are listed on the Nasdaq First North Growth Market Finland marketplace. www.duell.eu.

 

English, Finnish

Nordic Unmanned ASA – Registration of prospectus and upcoming launch of subsequent offering

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA, SOUTH AFRICA, NEW ZEALAND, JAPAN, THE UNITED STATES, THE UNITED KINGDOM OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.

Reference is made to the stock exchange announcement published by Nordic Unmanned ASA (the "Company") on 31 October 2024 regarding the successful private placement of 90,000,000 new shares in the Company at a price of NOK 0.50 per share (the "Private Placement") and that the Company intends to carry out a subsequent offering of up to 20,000,000 new shares, raising gross proceeds of up to NOK 10 million (the "Subsequent Offering").

For the purposes of the Subsequent Offering, the Company has prepared a national prospectus (the "Prospectus") which was registered with the Norwegian Register of Business Enterprises ("NRBE") today in accordance with Section 7-8 of the Norwegian Securities Trading Act. Neither the Norwegian Financial Supervisory Authority nor any other public authority has carried out any form of review, or approval of the Prospectus. The Prospectus is not an EEA prospectus pursuant to Regulation (EU) 2017/1129.

The Prospectus will be made available electronically at www.paretosec.com/transactions prior to the commencement of the Subscription Period (as defined below), expected on or about 25 November 2024.

The Subsequent Offering

The Subsequent Offering comprises an offer of up to 20,000,000 new shares (the "Subsequent Offer Shares") in the Company, each with a nominal value of NOK 0.25, at a subscription price of NOK 0.50 per share, with gross proceeds of up to NOK 10 million.

The Subsequent Offering will primarily, subject to applicable securities law, be directed towards existing shareholders in the Company as of 31 October 2024 (as registered in the VPS two trading days thereafter on 4 November 2024 (the "Record Date")), who (i) were not included in the pre-sounding phase of the Private Placement, (ii) were not allocated offer shares in the Private Placement, and (iii) are not resident in a jurisdiction where such offering would be unlawful or would (in jurisdictions other than Norway) require any prospectus, filing, registration or similar action (the "Eligible Shareholders").

Each Eligible Shareholder will receive 5.516168 non-transferable subscription rights in the Subsequent Offering for each share held by such Eligible Shareholder in the Company as of the Record Date, rounded down to the nearest whole right. Over-subscription with subscription rights will be allowed, however, there can be no assurance that Offer Shares will be allocated for such subscriptions. Further, subscription without subscription rights from investors other than the Eligible Shareholders will also be allowed in the Subsequent Offering.

The allocation hierarchy in the Subsequent Offering will be as follows:

  • Shares shall be allocated to Eligible Shareholders who have subscribed with subscription rights.
  • Unallocated shares following a) shall be allocated to Eligible Shareholders who have over-subscribed with subscription rights (on a pro rata basis).
  • Unallocated shares following b) shall be allocated to investors other than the Eligible Shareholders who have subscribed without subscription rights (the Company's board of directors (the "Board") reserves the right to allocate c) at their sole discretion (in consultation with the Manager (as defined below)).
  • The subscription period for the Subsequent Offering will commence on or about 25 November 2024 at 09:00 (CET) and will expire on or about 6 December 2024 at 16:30 (CET) (the "Subscription Period").

    In order to subscribe for Offer Shares, the Manager (as defined below) must receive a complete and duly signed subscription form within the end of the Subscription Period. Further instructions regarding the subscription procedure are available in the Prospectus. Subscriptions may only be made on the basis of the Prospectus. Subscribers who are residents of Norway with a Norwegian personal identification number (Nw.: fødselsnummer) may also, and are encouraged to, subscribe for Offer Shares through the VPS online subscription system (or by following the link on www.paretosec.com/transactions which will redirect the subscriber to the VPS online subscription system).

    Subscription Rights that are not used to subscribe for Offer Shares before the expiry of the Subscription Period will have no value and lapse without compensation to the holder.

    The due date for payment of the Offer Shares is on or about 11 December 2024 (the "Payment Date"). In order for payment to take place on the Payment Date, subscribers must ensure that there are sufficient funds on the bank account to be debited on or about 10 December 2024. Subject to timely payment by the subscribers, the Company expects that the share capital increase pertaining to the Offer Shares will be registered with the Norwegian Register of Business Enterprises ("NRBE") on or about 17 December 2024 and that the Offer Shares will be delivered to the applicant's VPS account and become tradable on or about 18 December 2024. The Offer Shares will have equal rights and rank pari passu with the Company's other shares.

    The completion of the Subsequent Offering is subject to (i) due payment of the Offer Shares by the subscribers, (ii) the Board resolving to approve the Subsequent Offering and issue and allocate the Offer Shares based on the authorization granted by the extraordinary general meeting of the Company held on 19 November 2024, (iii) registration of the share capital increase pertaining to the Subsequent Offering with the NRBE and delivery of the Offer Shares to the subscribers in Euronext Securities Oslo (VPS).

    ADVISORS

    Pareto Securities AS is acting as manager (the "Manager") in the Subsequent Offering.

    Advokatfirmaet Schjødt AS is acting as legal advisor to the Company.

    CONTACTS

    * Stig H. Christiansen, CEO, Nordic Unmanned ASA, +47 478 07 813, shc@nordicunmanned.com

    * Tarjei Lode, CFO, Nordic Unmanned ASA, +47 469 37 008, tl@nordicunmanned.com

     

    DISCLOSURE REGULATION

    This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

     

    ABOUT NORDIC UNMANNED

    NU Group is a leading European provider of advanced, drones, sensors, AI-powered drone solutions, and UAS-agnostic drone-as-a-service operations. The company serves government agencies, Ministries of Defence, security clients, and corporate clients, offering cutting-edge technology solutions for a wide range of applications, including:

    • Empowering defenders and protect lives
    • Autonomous efficiency and optimized operations
    • Safe and environmentally friendly collection of live, actionable data insights

    Founded in Norway in 2014, NU Group has offices in Sandnes (NO), Cranfield (UK), Hasselt (BE) and Arnsberg (GER). Nordic Unmanned ASA employs approx. 100 FTEs and is listed on Euronext Growth with the ticker NUMND. The Group's operating history is 20 years based on AirRobot in Germany.

    For more information visit - https://www.nugroup.eu/

    IMPORTANT INFORMATION

    This announcement is not and does not form a part of any offer to sell, or a solicitation of an offer to purchase, any securities of the Company. The distribution of this announcement and other information may be restricted by law in certain jurisdictions. Copies of this announcement are not being made and may not be distributed or sent into any jurisdiction in which such distribution would be unlawful or would require registration or other measures. Persons into whose possession this announcement or such other information should come are required to inform themselves about and to observe any such restrictions.

    The securities referred to in this announcement have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), and accordingly may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act and in accordance with applicable U.S. state securities laws. The Company does not intend to register any part of the offering or their securities in the United States or to conduct a public offering of securities in the United States. Any sale in the United States of the securities mentioned in this announcement will be made solely to "qualified institutional buyers" as defined in Rule 144A under the Securities Act.

    In any EEA Member State, this communication is only addressed to and is only directed at qualified investors in that Member State within the meaning of the Prospectus Regulation, i.e., only to investors who can receive the offer without an approved prospectus in such EEA Member State. The expression "Prospectus Regulation" means Regulation 2017/1129 as amended together with any applicable implementing measures in any Member State. This communication is only being distributed to and is only directed at persons in the United Kingdom that are (i) investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "Order") or (ii) high net worth entities, and other persons to whom this announcement may lawfully be communicated, falling within Article 49(2)(a) to (d) of the Order (all such persons together being referred to as "relevant persons").

    This communication must not be acted on or relied on by persons who are not relevant persons. Any investment or investment activity to which this communication relates is available only for relevant persons and will be engaged in only with relevant persons. Persons distributing this communication must satisfy themselves that it is lawful to do so.

    The information contained in this announcement speak only as at its date, and are subject to change without notice. The Company does not undertake any obligation to review, update, confirm, or to release publicly any revisions to any of the content of this announcement.

    Neither of the Company, the Manager nor any of their respective affiliates makes any representation as to the accuracy or completeness of this announcement and none of them accepts any responsibility for the contents of this announcement or any matters referred to herein. This announcement is for information purposes only and is not to be relied upon in substitution for the exercise of independent judgment. It is not intended as investment advice and under no circumstances is it to be used or considered as an offer to sell, or a solicitation of an offer to buy any securities or a recommendation to buy or sell any securities in the Company. Neither the Company, the Manager nor any of their respective affiliates accepts any liability arising from the use of this announcement.

    Disclosure regulation

    This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

    Contacts
    • Stig H. Christiansen, CEO, Nordic Unmanned ASA, +47 478 07 813, shc@nordicunmanned.com
    • Tarjei Lode, CFO, Nordic Unmanned ASA, +47 46937008, tl@nordicunmanned.com
    About Nordic Unmanned

    NU Group is a leading European provider of advanced, drones, sensors, AI-powered drone solutions, and UAS-agnostic drone-as-a-service operations. The company serves government agencies, Ministries of Defence, security clients, and corporate clients, offering cutting-edge technology solutions for a wide range of applications, including:

    • Empowering defenders and protect lives​
    • Autonomous efficiency and optimized operations​
    • Safe and environmentally friendly collection of live, actionable data insights​

    Founded in Norway in 2014, NU Group has offices in Sandnes (NO), Cranfield (UK), Hasselt (BE) and Arnsberg (GER). Nordic Unmanned ASA employs approx. 100 FTEs and is listed on Euronext Growth with the ticker NUMND. The Group’s operating history is 20 years based on AirRobot in Germany.

    For more information visit - https://www.nugroup.eu/

    Attachments
    • Download announcement as PDF.pdf
    English

    Schibsted ASA (SCHA/SCHB) - Mandatory disclosure of trades: Employee Share Saving Plan

    As part of the Employee Share Saving Plan, primary insiders in Schibsted ASA (“Schibsted Marketplaces”) have on 22 November 2024 purchased 370 treasury B-shares at a price of NOK 338.00 per B-share (the price is set according to standard procedure for the programme during a two day period subsequent to the release of Schibsted's Q3 2024 results, the closing price on 28 October 2024). The transaction is related to the second enrollment window in the Employee Share Saving Plan for 2024 which closed in June 2024, and based on savings made during July, August and September 2024.

    In addition, primary insiders in Schibsted ASA (“Schibsted Marketplaces”) received 335 treasury B-shares on 22 November 2024. The transaction is related to bonus matching shares given to employees who enrolled in the Employee Share Saving Plan for 2022.

    For more information on the Employee Share Saving Plan please refer to the disclosure published 9 April 2014.

    Please see the attached form(s) for notification and public disclosure of transactions.

    Oslo, 22 November 2024

    SCHIBSTED ASA

    Disclosure regulation

    This information is subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act.

    Contacts
    • Malin Ebenfelt, Investor Relations Officer, +47 916 86 710, ir@schibsted.com
    Attachments
    • Download announcement as PDF.pdf
    • RSU Primary Insider Altinn KRT 1500.pdf
    English

    Hydract registrerer sin kapitalforhøjelse

    Selskabsmeddelelse nr. 67

    Med henvisning til selskabsmeddelelse 65/2024, blev det oplyst at Hydract efter gennemført emission med fortegningsret havde modtaget tegning for i alt 68.316.760 Nye Aktier, svarende til en samlet kontant tegning på DKK 12.980.184,40. Selskabet har dags dato opdateret sine vedtægter og registreret kapitalforhøjelsen.

    Efter kapitalforhøjelsen er den nominelle aktiekapital på DKK 10.247.514 fordelt på 102.475.140 aktier à nominelt DKK 0,1 DKK. Hver aktie à nominelt DKK 0,1 giver én stemme, og det totale antal af stemmeretter i Selskabet er herefter 102.475.140.

    De nye aktier har samme fondskode, og samme rettigheder som de eksisterende aktier, og forventes at være i handel senest tirsdag d. 26. november 2024.

    Det skal understreges, at Selskabet har fået tilladelse fra Nasdaq til at afnotere og slette Selskabets aktier fra handel på Nasdaq First North Growth Market med sidste handelsdag d. 7. februar 2025, for uddybning heraf se selskabsmeddelelse 64/2024. Der vil i forbindelse med afnoteringen være risici/ulemper for de tilbageværende aktionærer, og for en uddybning heraf henvises til selskabsmeddelelse 56/2024 & 57/2024, hvor både baggrund, proces og konsekvenser for sletningen fra handel er grundigt beskrevet.

    Kontakter
    • Hydract A/S, CEO, Peter Espersen, +45 61 85 10 00, peter.espersen@hydract.dk
    • Norden CEF A/S, Certified Adviser, John Norden
    Om Hydract A/S

    Hydracts mission er at udvikle ventiler og andre produkter og services, som bidrager markant til den grønne omstilling i procesindustrier, hvor der stilles krav til hygiejnisk produktion, og som samtidig skaber betydelige konkurrencefordele for Hydracts kunder. Hydract vil udbrede Hydract-teknologien globalt, drevet af kundernes behov for løsninger der forbedrer deres time-to-market, produktspild, klimaaftryk, energiomkostninger og fødevaresikkerhed. Se mere på vores hjemmeside   Hydract.com

    Vedhæftninger
    • Download selskabsmeddelelse.pdf
    Danish

    Indkaldelse til ordinær generalforsamling i Scandinavian Medical Solutions Group

    SELSKABSMEDDELELSE NR. 48 – 2024 | 22-11-2024

    Ordinær generalforsamling – Aalborg 

    Scandinavian Medical Solutions A/S afholder ordinær generalforsamling mandag, den 9. december 2024, kl. 10.00 på selskabets adresse Gasværksvej 48, 1. sal DK-9000 Aalborg.  

    Vedlagt indkaldelse til ordinær generalforsamling i Scandinavian Medical Solutions A/S med dagsorden og fuldstændige forslag. 

    Scandinavian Medical Solutions A/S (Nasdaq First North Growth Market Denmark: Ticker SMSMED) er forpligtet til at offentliggøre den ovenstående information i henhold til EU-Markedsmisbrugsforordningens punkt 17. 

    Supplerende Information 

    For spørgsmål vedrørende denne selskabsmeddelelse kan Selskabets CEO, Jens Hvid Paulsen, kontaktes på investor@scandinavian-medical.com.   

    Selskabets Certified Adviser er Norden CEF A/S.  

    Scandinavian Medical Solutions A/S 

    Gasværksvej 48,1., DK – 9000 Aalborg  

    CVR-nummer: 39901749  

    Hjemmeside: www.scandinavian-medical.com  

    Selskabsmeddelelser, investornyheder, finansielle rapporter mv. kan findes på https://www.scandinavian-medical.com/pages/investors  

    Om Selskabet 

    Scandinavian Medical Solutions blev stiftet tilbage i 2018 med en mission om at facilitere bedre adgang til omkostningseffektivt og højkvalitets billeddiagnostisk udstyr globalt gennem specialiseret indkøb og videresalg af brugt billeddiagnostisk udstyr af høj kvalitet.    

    MRI, CT og PET/CT-scannere er blandt det dyreste og mest komplekse udstyr, der findes på et hospital, og de tonstunge følsomme maskiner kan kun transporteres, samles og vedligeholdes af specialiserede fagfolk med erfaring og tekniske færdigheder.    

    Derfor tilbyder Scandinavian Medical Solutions en komplet business til business løsning, som garanterer maskinens kvalitet og funktionalitet.    

    Scandinavian Medical Solutions tilbyder hospitaler og klinikker verden over et tilgængeligt, pålideligt og bæredygtigt økosystem for handel med scanningsudstyr og skaber dermed grundlag for en cirkulær økonomi, hvor eksisterende materiel får nyt liv.    

    Vedhæftninger
    • Download selskabsmeddelelse.pdf
    • Indkaldelse_til_GF_og_dagsorden_24.pdf
    Danish

    Admicom Oyj: Arvopaperimarkkinalain 9 luvun 10 pykälän mukaisen ilmoituksen peruutus

    Admicom Oyj: Arvopaperimarkkinalain 9 luvun 10 pykälän mukaisen ilmoituksen peruutus

    Admicom Oyj on vastaanottanut ilmoituksen, jonka mukaan Arvopaperimarkkinalain 9. luvun 5 §:n mukaisesti Danske Bank A/S:n omistusosuus Yhtiön osakkeista ja äänistä ei ole laskenut alle viiteen (5) prosenttiin 19.11.2024, toisin kuin 20.11.2024 julkaistussa ilmoituksessa tiedotettiin. Alla tiedot ajantasaisista omistusosuuksista.

    Liputusvelvollisen osuus

     

    % osakkeista ja äänistä 

    % osakkeista ja äänistä rahoitusvälineiden kautta

    Yhteenlaskettu %-osuus

    Kohdeyhtiön osakkeiden ja äänten kokonaismäärä

    Osuus liputusrajan saavuttamisen tai rikkoutumisen jälkeen

    7,05 %

    0

    7,05 %

    4 988 985

    Edellisessä liputusilmoituksessa ilmoitettu osuus (jos liputettu)

              8,2 %

     0

                   8,2 % 

              4 988 985

    Tiedot omistus- ja ääniosuudesta liputusrajan saavuttamisen tai rikkoutumisen jälkeen

    A: Osakkeet ja äänet

     

    Osakkeiden ja äänten lukumäärä

    Osakkeiden ja äänten %-osuus

    Osakesarja / osakelaji (ISIN-koodi)

    Suora(AML 9:5)

    Välillinen(AML 9:6 ja 9:7)

    Suora(AML 9:5)

    Välillinen(AML 9:6 ja 9:7)

    FI4000251830

    0

    351 501

    0

    7,05 % 

    A YHTEENSÄ

    351 501

    7,05 % 

     

    Admicom Oyj

    Lisätietoja antaa:

    Satu HelamoTalousjohtajasatu.helamo@admicom.com+358 45 633 7710

    Hyväksytty neuvonantaja:

    Oaklins Finland Oy+358 9 6129 670

    Tietoja julkaisijasta Admicom Oyj

    Admicom Oyj

    Admicom on vuonna 2004 perustettu pk-yritysten järjestelmäkehityksen edelläkävijä ja kokonaisvaltainen ohjelmisto- ja tilitoimistokumppani.

    Palvelukokonaisuutemme ytimessä on Admicom Ultima -toiminnanohjausjärjestelmä (aiemmin Adminet), joka kattaa laajasti ratkaisut asiakasyritysten toimintojen hallintaan työmaan mobiilityökaluista aina reaaliaikaiseen talousseurantaan ja projektien hallintaan. Pitkälle automatisoitu SaaS-ratkaisu auttaa pk-yrityksiä parantamaan kilpailukykyään ja kannattavuuttaan sekä säästää merkittävästi aikaa työmaalla ja toimistossa. Tarjoamme asiakkaillemme myös koulutus-, konsultointi- ja tilitoimistopalveluita.

    Ohjelmistoperheeseemme kuuluvat myös pienyritysten kustannustehokas ohjelmisto- ja palvelupaketti Ultima Lite (aiemmin Adminet Lite), liikkuvan työn ohjauksen täsmäratkaisu Admicom Flex (aiemmin Hillava), nykyaikaisia ratkaisuja laadukkaampaan dokumentointiin tarjoava Admicom Vision (aiemmin Kotopro) sekä projektinhallintayksikkö, jonka palveluvalikoimaan kuuluvat ratkaisut määrä- ja kustannuslaskentaan (Estima ja Estima Pro), kustannusraportointiin (Insite, aiemmin Tocoman Raportointi), aikataulutukseen (Tempo ja Planner, aiemmin Tocoman Aikataulu) sekä BIM3-ratkaisut tietomallien hyödyntämiseen.

    Työskentelemme jatkuvasti ohjelmistoperheemme toimintojen yhteensovittamiseksi, jotta voimme tarjota asiakkaillemme yhdenmukaisen käyttökokemuksen järjestelmien välillä ja poistaa ylimääräisiä työvaiheita mahdollistaen asiakkaillemme kannattavamman liiketoiminnan nykyaikaisia ohjelmistoratkaisuja hyödyntäen.

    Jatkuvasti kasvava Admicommunity työllistää yli 270 henkilöä Jyväskylässä, Helsingissä, Tampereella, Oulussa, Seinäjoella ja Turussa sijaitsevissa toimipisteissään. Lisätietoa: www.admicom.com.

    Admicomin tiedotteet ja tulosraportit: https://sijoittajille.admicom.fi/tiedotteet-ja-julkaisut/

    JAKELU

    Nasdaq Helsinki OyKeskeiset tiedotusvälineet

    Finnish

    Thor Medical signs agreement for supply of Pb-212 for pre-clinical use with globally leading pharmaceutical company

    Oslo, 22 November, 2024: Thor Medical, a leading emerging supplier of alpha-emitters for next-generation precision cancer treatment, has signed an agreement with a globally leading pharmaceutical company for the supply of Pb-212 alpha-emitters for use in pre-clinical studies.

    Thor Medical will supply the Pb-212 isotopes from its newly established Herøya pilot facilities. Pb-212, or Lead-212, is a therapeutic radioisotope for precision cancer treatment with a short half-life, derived from the Thorium-228 decay. Deliveries will commence in 2025 under a three-year supply agreement.

    “While the volumes under this agreement reflect that the intended use is for pre-clinical studies and evaluation and not commercial scale, this agreement highlights our ability to establish contracts with major players in the pharmaceutical industry, demonstrating trust in our capabilities to deliver the high-quality radioisotopes required to enable highly promising next-generation precision cancer treatments,” says Jasper Kurth, CEO of Thor Medical.

    This supply agreement adds to recent milestones including the signing of a strategic long-term supply agreement of Thorium-228 to ARTBIO, and the recent first shipment of product samples from the Herøya pilot facility to another undisclosed potential customer.

    On 25 November, Thor Medical will host a Capital Markets Update in Stockholm, featuring presentations from both Thor Medical and ARTBIO.

    CONTACT 

    Thor Medical Brede Ellingsæter, CFO, +47 472 38 440 

    brede.ellingseter@thormedical.com

    ABOUT THOR MEDICAL ASA

    Thor Medical is an emerging supplier of alpha particle emitters produced from naturally occurring thorium. Its proprietary production process requires no irradiation or use of nuclear reactors, and provides reliable, environmentally friendly, cost-efficient supply of alpha-emitters for the radiopharmaceutical industry. Thor Medical is headquartered in Oslo, Norway and listed on the Oslo Stock Exchange under the ticker symbol 'TRMED'.

    IMPORTANT INFORMATION 

    This information is considered to be inside information pursuant to the EU Market Abuse Regulation (MAR) and is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act. The stock exchange announcement was published by Brede Ellingsæter, CFO, Thor Medical ASA, at the time and date stated above in this announcement. 

    This release contains forward -looking information and statements relating to the business, performance, and matters that may impact the results of Thor Medical. Forward-looking statements are statements that are not historical facts and may be identified by words such as "aims," "anticipates," "believes," "estimates," "expects," "foresees," "intends," "plans," "predicts," "projects," "targets," "potential," and similar expressions. Such forward-looking statements are based on current expectations, estimates, and projections, reflect current views concerning future events, and are subject to risks, uncertainties, and assumptions, and may be subject to change without notice. Forward-looking statements are not guarantees of any future performance, and risks, uncertainties, and other important factors could cause the actual business, performance, results, or the industry and markets in which Thor Medical operates to differ materially from the statements expressed or implied in this release by such forward-looking statements. No representation is made that any of these forward-looking statements or forecasts will come to pass or that any forecasted performance, capacities, or results will be achieved, and you are cautioned not to place any undue reliance on any forward-looking statements.

    This release is for information purposes only and is not to be relied upon in substitution for the exercise of independent judgment. It is not intended as investment advice and under no circumstances is it to be used or considered as an offer to sell, or a solicitation of an offer to buy any securities or a recommendation to buy or sell any securities of the Company.

    Attachments
    • Download announcement as PDF.pdf
    English

    Upward adjustment of expectations for the financial year 2023/24

    Based on the preliminary and non-audited financial figures, Per Aarsleff Holding A/S estimates that the Group’s revenue for the entire financial year 2023/24 will exceed expectations and add up to approximately DKK 21.7 billion against the previous announcements of DKK 21-21.4 billion.

    There is also an increase in the Group’s EBIT which is now estimated to approximately DKK 1,100 million against the previously announced range of DKK 1,000-1,050 million. The positive change is based on the Group’s segment Ground Engineering that reports significantly increased earnings above expectations in the fourth quarter, and because the segments Pipe Technologies, Rail and Construction are reporting slightly higher earnings. The segment Technical Solutions is reporting figures within the already expected range.

    The annual report of 2023/24 of Per Aarsleff Holding A/S will be published according to plan on Thursday 19 December 2024.

    Contacts
    • Jesper Kristian Jacobsen, Administrerende koncerndirektør / Group CEO, +45 8744 2222
    About Per Aarsleff Holding A/S

    The Aarsleff Group is a building construction and civil engineering group with an international scope and a market leading position in Denmark. The Group comprises a portfolio of independent, competitive companies each with their own specialist expertise. 

    Attachments
    • Aarsleff selskabsmeddelelse 1124 UK.pdf
    Danish, English

    Wulff Group Plc’s financial reporting and Annual General Meeting 2025

    STOCK EXCHANGE RELEASE | NOVEMBER 21, 2024 AT 5.15 P.M.

    Wulff Group Plc will release the following financial reports in 2025:

    Financial Statements Release 2024 Monday February 17, 2025 Annual Report 2024 Wednesday March 5, 2025 Interim Report January-March 2025 Monday April 28, 2025 Half-Year Report January-June 2025 Thursday July 17, 2025 Interim Report January-September 2025 Monday October 20, 2025

    The release time is approximately 9:30 a.m. on the release date.

     

    The Annual General Meeting of Wulff Group Plc will be held on Thursday April 3, 2025. The notice of the Annual General Meeting will be published separately before the meeting in 2025.

     

    Wulff Group Plc's financial releases and IR calendar are available on our website.

     

    In Espoo on November 21, 2024

    WULFF GROUP PLCBOARD OF DIRECTORS

    Further information: CEO Elina Rahkonentel. +358 40 647 1444 e-mail: elina.rahkonen@wulff.fi

    DISTRIBUTIONNasdaq Helsinki OyKey mediawww.wulff.fi/en

    A better world - one workplace at a time. A perfect working day with worklife services and products for work environment - responsibly with Wulff. Here you can find today’s workplace products: e.g. cafe supplies, real estate and cleaning maintenance products, office and IT supplies, ergonomics, first aid, hygiene, protection and safety products, air purification, and innovative products for construction sites. Our selection also includes high-quality Canon printing and document management services as well as financial management services. Our customers also purchase international exhibition services and solutions for remote meetings from us. It is important for us to constantly develop our product range to be more and more sustainable and our customer experience to be the best in the field. Staff leasing is one of our newest service additions. In addition to Finland, Wulff Group operates in Sweden, Norway, and Denmark.

    Attachments
    • Wulff Group Plc’s financial reporting and Annual General Meeting 2025.pdf
    English, Finnish

    Scandinavian Medical Solutions A/S sælger GE MRI-scanner til amerikansk kunde

    Investornyhed nr. 85 – 2024 | 21-11-2024  

    I sidste uge kunne Scandinavian Medical Solutions (’SMS’ eller ’Selskabet’) offentliggøre månedens første investornyhed vedrørende et salg med en ordreværdi over DKK 2.000.000. I dag kan SMS offentliggøre endnu et succesfuldt salg. Denne gang en GE MRI-scanner, der er solgt til en amerikansk kunde. Det er den danske salgsorganisation, der har håndteret salget.  

    Salget udgør et beløb større end DKK 2.000.000 og offentliggøres derfor i henhold til Selskabets informations – og kommunikationspolitik. Ordren ligger inden for intervallet DKK 2.000.000 til under DKK 3.500.000. 

    Scanneren er blevet overleveret til køberen i uge 47, 2024, og køberen har herefter selv varetaget transporten. Ordren ændrer ikke på nyligt udmeldt guidance for omsætning og EBITDA i regnskabsåret 2024/2025.   

     

    Supplerende Information   

    For spørgsmål vedrørende denne investornyhed kan selskabets CEO, Jens Hvid Paulsen, kontaktes på investor@scandinavian-medical.com.    

    Selskabets Certified Adviser er Norden CEF A/S.    

    Scandinavian Medical Solutions A/S   

    Gasværksvej 48,1., DK – 9000 Aalborg   

    CVR-nummer: 39901749    

    Hjemmeside: www.scandinavian-medical.com    

    Selskabsmeddelelser, investornyheder, finansielle rapporter mv. kan findes på https://www.scandinavian-medical.com/pages/investors   

     

    Om Selskabet   

    Scandinavian Medical Solutions blev stiftet tilbage i 2018 med en mission om at facilitere bedre adgang til omkostningseffektivt og højkvalitets billeddiagnostisk udstyr globalt gennem specialiseret indkøb og videresalg af brugt billeddiagnostisk udstyr af høj kvalitet.    

    MRI, CT og PET/CT-scannere er blandt det dyreste og mest komplekse udstyr, der findes på et hospital, og de tonstunge følsomme maskiner kan kun transporteres, samles og vedligeholdes af specialiserede fagfolk med erfaring og tekniske færdigheder.   Derfor tilbyder Scandinavian Medical Solutions en komplet business til business løsning, som garanterer maskinens kvalitet og funktionalitet.    

    Scandinavian Medical Solutions tilbyder hospitaler og klinikker verden over et tilgængeligt, pålideligt og bæredygtigt økosystem for handel med scanningsudstyr og skaber dermed grundlag for en cirkulær økonomi, hvor eksisterende materiel får nyt liv.  

    Vedhæftninger
    • Download selskabsmeddelelse.pdf
    Danish

    Resolutions of Eagle Filters Group Plc's Extraordinary General Meeting

    Resolutions of Eagle Filters Group Plc's Extraordinary General Meeting

    The Extraordinary General Meeting of Eagle Filters Group Plc was held on 21 November 2024 in Helsinki. A total of 6 shareholders and 99,163,564 shares and votes were represented in the meeting. The Extraordinary General Meeting approved all the proposals made by the Board of Directors to the General Meeting.

    The number of members of the Board of Directors was resolved to be five. Mr. Jukka Heikka was elected as new member of the Board of Directors for a term that will continue until the close of the next Annual General Meeting. Other current members of the Board of Directors continue in their position until the close of the next Annual General Meeting.

     

    For more information:Jarkko Joki-Tokola, CEO, Eagle Filters Group Oyj, jarkko@eaglefiltersgroup.com

    About Eagle Filters Group Oyj

    Eagle Filters Group is a material science company that aims to enable a green and healthy environment.

    Eagle provides high performance filtration solutions that cut CO2 emissions and increase profitability of the energy industry. Eagle’s technology improves performance and energy efficiency while cutting costs. The technology is being used by some of the world’s largest energy utilities.

    The company group is listed on First North Growth Market Finland under the ticker EAGLE. The Company’s Certified Adviser is Carnegie Investment Bank AB (publ).

    www.eaglefiltersgroup.com 

    Attachments
    • Download announcement as PDF.pdf
    English

    Flot forretningsvækst og stærk kreditkvalitet

    Arbejdernes Landsbank Koncernen, der har Vestjysk Bank (73 pct. ejerskab) og AL Finans som datterselskaber, kommer ud af årets første 9 måneder med et samlet resultat på 1.849 mio. kr. før skat, og det er lidt bedre end forventet.

    Arbejdernes Landsbank Koncernens regnskab til og med tredje kvartal 2024 byder på et overskud på 1.849 mio. kr. før skat. Sammenlignet med samme tidspunkt sidste år (1.821 mio. kr.) er det en forbedring på 28 mio. kr. svarende til en forbedring på 1,5 pct.

    “Koncernen har i årets første tre kvartaler haft en bred vækst i forretningsomfanget på 5,8 pct. Der har især været god fart på udlånet, som er steget med 7,2 pct. i løbet af 2024. Det kan vi kun være tilfredse med,” siger viceadministrerende direktør Frank Mortensen. 

    Han fremhæver ligeledes koncernens nedskrivninger, som viser en indtægt som følge af forbedrede makroøkonomiske udsigter og stærk kreditkvalitet. Koncernen kan således tilbageføre 117 mio. kr. på nedskrivninger.

    ”Vi havde forventet en normalisering af nedskrivningsniveauet i 2024 og dermed negative nedskrivninger. Men vi er endnu en gang blevet positivt overraskede. Vi kan konstatere, at vores kunder stadig har det godt og er i stand til at tilbagebetale deres lån, og det er vi selvfølgelig glade for,” siger Frank Mortensen. 

    Med det aktuelle resultat efter årets første ni måneder fastholder Arbejdernes Landsbank Koncernen forventningen om et årsresultat i niveauet 2,0-2,4 mia. kr. før skat.

    Højt renteniveau og fine afkast på investeringerDet forholdsvist høje renteniveau i 2024 – særligt i første halvår – har påvirket koncernens investeringsaktiviteter og kundeaktiviteter positivt. Nettorenteindtægterne på 2.482 mio. kr. år-til-dato er således 55 mio. kr. højere end ved samme tid i 2023.

    ”Vi forventer dog, at renteindtægterne har toppet, da der har været en nedadgående trend igennem 2024,” tilføjer Frank Mortensen.

    Kursreguleringer og udbytte på 529 mio. kr. udgør en stigning på 84 mio. kr. (18,9 pct.) i 2024 sammenlignet med samme tidspunkt i 2023.

    Stigning i både udlån og indlån Koncernen oplever fortsat vækst i forretningsomfanget på alle områder. Koncernens samlede udlån er foreløbig vokset med 7,2 pct. i løbet af 2024 (mod 5,7 pct. ved samme tidspunkt sidste år). Indlån er steget med 4,0 pct. (3,2 pct. ved samme tidspunkt sidste år).

    Omkostningerne er som forventet steget i forhold til sidste år som følge af flere ansatte, overenskomstmæssig lønstigning og højere IT-udgifter.

    Årsresultat og årsrapport for 2024 offentliggøres den 5. februar 2025. 

    Kontakter
    • Martin Sejer Lützen, Kommunikation, 38484746, msl@al-bank.dk
    Om Aktieselskabet Arbejdernes Landsbank

    Arbejdernes Landsbank er den 6. største bank i Danmark med ca. 350.000 kunder, 1.200 ansatte og 59 filialer fordelt over hele landet.

    Banken tilbyder finansielle produkter og ydelser kombineret med ansvarlig rådgivning til private, foreninger og små og mellemstore virksomheder. Banken er 15 år i træk kåret til danskernes foretrukne bank i den største uafhængige tilfredshedsundersøgelse af danske banker (Voxmeter 2024).

    Det er vores mål, at rådgivningen skal skabe værdi for kunden, og at serviceniveauet hører til et af landets absolut højeste. På det værdigrundlag driver vi en sund bank med en solid økonomi og med stor respekt for vores kunders tid og penge.

    Vedhæftninger
    • Download selskabsmeddelelse.pdf
    Danish

    BactiQuant modtager ny ordre på vores prøvetagningsrobot

    BactiQuant A/S har i dag modtaget en ny ordre på flere prøvetagningsrobotter af typen BactiQuant Online 2.0 PRO.

    Dette er insiderviden

    Det glæder BactiQuant at meddele, at vi netop har modtaget endnu en ordre på leverance af vores on-line prøvetagningsrobot fra vores pharmasegment. Prøvetagningsrobotterne skal leveres i årets sidste kvartal. Ordren ændrer ikke udmeldt guidance for 2024. 

    Selskabet (Nasdaq First North Growth Market Denmark : BACTIQ.CO) er forpligtet til at offentliggøre den ovenstående information i henhold til EU Markedsmisbrugsforordning punkt 17.

    Kontakter
    • Henrik Enegaard Skaanderup, Bestyrelsesformand, +4540334470, henrik-skaanderup@mail.dk
    • John Norden, Certificeret rådgiver til Nasdaq First North, +4520700200, jn@nordencef.dk
    • Morten Miller, Chief Executive Officer CEO/CINO, +4523678732, miller@bactiquant.dk
    Om BactiQuant A/S

    Bactiquant has developed a technology that will revolutionize the monitoring of bacterial contamination levels in water and ensure optimum usage and handling of water around the world to the benefit of our customers and the sustainability of our planet. To show our environmental commitment, we have aligned our business with four of the UN's Sustainable Development Goals. We believe that Bactiquant will be the world leader within mobile and online surveillance of bacterial contamination levels, and we are already well on our way. Headquartered in Denmark and operating across five continents, our customers come from a wide range of industries such as public water utility companies, industries needing water cooling or requiring wastewater treatment, and aquaculture.

    Vedhæftninger
    • Download selskabsmeddelelse.pdf
    Danish

    Nordic Unmanned ASA – New share capital registered

    Reference is made to the stock exchange announcement published by Nordic Unmanned ASA (the "Company") on 19 November 2024 regarding the extraordinary general meeting held in the Company on the same date (the "EGM") and the approval of all proposals, hereunder a share capital increase through a private placement on 90,000,000 new shares in the Company (the "Share Capital Increase"), with simultaneous reduction of the par value of the Company's shares from NOK 1.00 to NOK 0.25 (the "Share Capital Reduction").

    The Share Capital Reduction and the Share Capital Increase have today been registered with the Norwegian Register of Business Enterprises (Nw.: Foretaksregisteret).

    The offer shares in the private placement are tradable on Euronext Growth Oslo as of this announcement.

    The Company's new registered share capital is NOK 26,834,078.25, divided on 107,336,313 shares, each with a nominal value of NOK 0.25.

    Please see attached a copy of the minutes from the extraordinary general meeting.

    DISCLOSURE REGULATION

    This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

    CONTACTS

    * Stig H. Christiansen, CEO, Nordic Unmanned ASA, +47 478 07 813, shc@nordicunmanned.com

    * Tarjei Lode, CFO, Nordic Unmanned ASA, +47 469 37 008, tl@nordicunmanned.com  

     

    ABOUT NORDIC UNMANNED

    NU Group is a leading European provider of advanced, drones, sensors, AI-powered drone solutions, and UAS-agnostic drone-as-a-service operations. The company serves government agencies, Ministries of Defence, security clients, and corporate clients, offering cutting-edge technology solutions for a wide range of applications, including:

    • Empowering defenders and protect lives
    • Autonomous efficiency and optimized operations
    • Safe and environmentally friendly collection of live, actionable data insights

    Founded in Norway in 2014, NU Group has offices in Sandnes (NO), Cranfield (UK), Hasselt (BE) and Arnsberg (GER). Nordic Unmanned ASA employs approx. 100 FTEs and is listed on Euronext Growth with the ticker NUMND. The Group's operating history is 20 years based on AirRobot in Germany.

    For more information visit - https://www.nugroup.eu/

    Disclosure regulation

    This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

    Contacts
    • Stig H. Christiansen, CEO, Nordic Unmanned ASA, +47 478 07 813, shc@nordicunmanned.com
    • Tarjei Lode, CFO, Nordic Unmanned ASA, +47 46937008, tl@nordicunmanned.com
    About Nordic Unmanned

    NU Group is a leading European provider of advanced, drones, sensors, AI-powered drone solutions, and UAS-agnostic drone-as-a-service operations. The company serves government agencies, Ministries of Defence, security clients, and corporate clients, offering cutting-edge technology solutions for a wide range of applications, including:

    • Empowering defenders and protect lives​
    • Autonomous efficiency and optimized operations​
    • Safe and environmentally friendly collection of live, actionable data insights​

    Founded in Norway in 2014, NU Group has offices in Sandnes (NO), Cranfield (UK), Hasselt (BE) and Arnsberg (GER). Nordic Unmanned ASA employs approx. 100 FTEs and is listed on Euronext Growth with the ticker NUMND. The Group’s operating history is 20 years based on AirRobot in Germany.

    For more information visit - https://www.nugroup.eu/

    Attachments
    • Download announcement as PDF.pdf
    English

    Andfjord Salmon: Invitation to Q3 2024 results presentation

    Andfjord Salmon Group AS (Andfjord Salmon) invites investors, analysts, lenders and media to an operational update and presentation of the company’s third quarter 2024 financial results.

    The presentation will be held physically in Oslo and streamed live to online viewers.

    Date:  Thursday 28 November 2024Time:  08:00 CETPresenters:  Martin Rasmussen, CEO, and Bjarne Martinsen, CFOVenue: Haakon VIIs gate 2, Vika, Oslo (Auditorium H2)

    The webcast presentation can also be watched from this URL: https://channel.royalcast.com/landingpage/hegnarmedia/20241128_1/

    The presentation will be held in English. Questions can be submitted during the live webcast.

    The presentation material will be published at 07:00 CET on the same day.

    Contacts
    • Investors: Bjarne Martinsen, CFO, Andfjord Salmon Group AS, +47 975 08 345, bjarne.martinsen@andfjord.no
    • Media: Martin Rasmussen, CEO, Andfjord Salmon Group AS, +47 975 08 665, martin@andfjord.no
    About Andfjord Salmon

    Located at Andøya on the Arctic Archipelago of Vesterålen, Norway, Andfjord Salmon is developing the world’s most sustainable and fish-friendly aquaculture facility of its kind. Through a proprietary flow-through system, Andfjord Salmon combines the best from ocean and land-based salmon farming. In its first production cycle, the company achieved an industry-leading survival rate of 97.5 percent, feed conversion ratio of 1.05, superior share of 91.1 percent, and required 1 kWh to produce one kilo of salmon. Andfjord Salmon has identified a roadmap towards a production capacity of 40,000 tonnes HOG at Kvalnes, Andøya, and set a long-term ambition to reach 90,000 tonnes HOG across Kvalnes, Breivika and Fiskenes at Andøya. For more information, see www.andfjordsalmon.com.

    English